Related Experiment Video
Updated: Nov 15, 2025

09:25
Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection
Published on: May 24, 2020
5.5K
Designing transmissible viral vaccines for evolutionary robustness and maximum efficiency
Nathan C Layman1, Beth M Tuschhoff2, Scott L Nuismer1
1Department of Biological Sciences.
Virus Evolution
|March 8, 2021
Summary
Transmissible vaccines show promise for controlling zoonotic diseases in wildlife. However, evolutionary changes can reduce their effectiveness, but adding a second antigen may improve stability and performance.
Area of Science:
- Veterinary Science
- Epidemiology
- Evolutionary Biology
Background:
- Emerging infectious diseases pose significant risks, necessitating novel tools to prevent zoonotic spillover.
- Transmissible vaccines offer a promising strategy for controlling animal pathogens in wildlife reservoirs.
- Recombinant viral vaccines that self-disseminate can reduce the effort needed for disease control in hard-to-reach populations.
Purpose of the Study:
- To investigate the impact of evolutionary trade-offs on the performance of transmissible vaccines.
- To determine how efficacy and evolutionary stability influence vaccine effectiveness.
- To explore strategies for improving vaccine stability and overall performance.
Main Methods:
- Mathematical modeling was used to simulate the dynamics of transmissible vaccines.
- The study analyzed the effects of evolutionary changes on vaccine efficacy and transmission rates.
- The influence of vaccine antigen design, including redundancy, was evaluated.
Main Results:
- Evolutionary instability can significantly impair transmissible vaccine performance, even with optimal efficacy and transmission.
- A trade-off exists between vaccine efficacy and evolutionary stability, where more efficacious antigens may decay faster.
- Including a second, redundant antigen can enhance vaccine stability and overall performance in some cases.
Conclusions:
- The successful deployment of transmissible vaccines requires careful consideration of evolutionary dynamics and epistatic effects.
- Understanding epidemiological features alongside evolutionary pressures is crucial for designing effective and stable vaccines.
- Redundant antigen strategies may offer a viable approach to mitigate evolutionary decay and improve vaccine longevity.
Related Concept Videos
Viral Mutations
37.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
37.2K
Size and Structure of Viral Genomes
380
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
380
Transduction
570
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
570

